Journal of IiME Volume 9 Issue 1 IIMEC10 pre-conference dinner. Vitae Natural Nutrition is a laboratory that develops natural products based on Science and nutraceutical technology, designed to activate, improve and regulate the biological processes of the body maintaining and extending its functions. Following the vision of a healthier world to live in, Vitae have made important progress in the food supplement field and have generated results. The goal of the team is to invest in progress, seeking more natural solutions through innovation. The cornerstone of the research team is to find more efficient natural solutions through the use of innovation. Vitae have a number of reputable research partners and team members including: Qualified scientists Multifaceted Professionals Strong partnerships with Health Centers, Hospitals, and endorsements from Universities. We would also like to thank three of our European ME Alliance colleagues for their great support in sponsoring the conference. The Irish ME Trust, who have supported all our conferences, deserve a special mention. Our European ME Alliance partners in Sweden and Norway have proven to be also contributed to the conference costs. The Swedish RME group and Norges ME Forening have both generously donated to the conference costs. We are very proud to have received such wonderful support from our European ME Alliance colleagues. May 2015 Our Research IMET and RME Sweden also recently donated to the Invest in ME Biomedical Research Fund (BRF) to help us in progressing our base of highquality biomedical research in Europe. Our two major areas of research currently revolve around the gut microbiota studies and the rituximab/B-cell research - a solid foundation of biomedical research which is being augmented with new collaborations. The donations help us with the work being performed by the IFR/UEA in collaboration with Angela Vincent at Oxford University as she has expertise and interest in the role of autoimmunity in neurological diseases, including multiple sclerosis and auto-antibody mediated ion channel and receptor disorders. This is very topical in light of the clues from the Norwegian rituximab trials as well as recent research that has come from the Chronic Fatigue Initiative funded by the Hutchins Family Foundation. These studies published by Hornig et al include a serum and a cerebrospinal fluid study. The abstract of the cerebrospinal fluid (CSF) study states – "Our results indicate a markedly disturbed immune signature in the cerebrospinal fluid of cases that is consistent with immune activation in the central nervous system, and a shift toward an allergic or T helper type-2 pattern associated with autoimmunity."• These new donations have consolidated the research efforts at the Norwich Research Park where we now have a unique opportunity to establish, for good, our Centre of Excellence for ME using high-quality biomedical research and state-of-the-art research and treatment facilities. Invest in ME (Charity Nr. 1114035) www.investinme.org Page 7 of 57

8 Publizr Home

You need flash player to view this online publication